Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells

被引:1
|
作者
Faircloth, Tyler U. [1 ]
Temple, Sara [1 ]
Parr, Rhett N. [1 ]
Tucker, Anna B. [1 ]
Rajan, Devi [1 ]
Hematti, Peiman [2 ]
Kugathasan, Subra [3 ,4 ]
Chinnadurai, Raghavan [1 ]
机构
[1] Mercer Univ, Sch Med, Dept Biomed Sci, 250 E 66th St, Macon, GA 31404 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[3] Emory Univ, Sch Med, Div Pediat Gastroenterol, Dept Pediat, Atlanta, GA USA
[4] Childrens Healthcare Atlanta, Atlanta, GA USA
关键词
mesenchymal stromal/stem cells; secretome; angiogenic factors; immunosuppression; human large intestinal endothelial cells; vascular endothelial growth factor A; INFLAMMATORY-BOWEL-DISEASE; OXIDE SYNTHASE INHIBITOR; NITRIC-OXIDE; STEM-CELLS; CROHNS-DISEASE; INTERNATIONAL SOCIETY; ANGIOGENIC PROPERTIES; PERIANAL FISTULAS; INTERFERON-GAMMA; L-NMMA;
D O I
10.1093/stmcls/sxae040
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stromal cells (MSCs) are investigated as cellular therapeutics for inflammatory bowel diseases and associated perianal fistula, although consistent efficacy remains a concern. Determining host factors that modulate MSCs' potency including their secretion of angiogenic and wound-healing factors, immunosuppression, and anti-inflammatory properties are important determinants of their functionality. We investigated the mechanisms that regulate the secretion of angiogenic and wound-healing factors and immune suppression of human bone marrow MSCs. Secretory analysis of MSCs focusing on 18 angiogenic and wound-healing secretory molecules identified the most abundancy of vascular endothelial growth factor A (VEGF-A). MSC viability and secretion of other angiogenic factors are not dependent on VEGF-A secretion which exclude the autocrine role of VEGF-A on MSC's fitness. However, the combination of inflammatory cytokines IFN gamma and TNF alpha reduces MSC's VEGF-A secretion. To identify the effect of intestinal microvasculature on MSCs' potency, coculture analysis was performed between human large intestine microvascular endothelial cells (HLMVECs) and human bone marrow-derived MSCs. HLMVECs do not attenuate MSCs' viability despite blocking their VEGF-A secretion. In addition, HLMVECs neither attenuate MSC's IFN gamma mediated upregulation of immunosuppressive enzyme indoleamine 2,3-dioxygenase nor abrogate suppression of T-cell proliferation despite the attenuation of VEGF-A secretion. We found that HLMVECs express copious amounts of endothelial nitric oxide synthase and mechanistic analysis showed that pharmacological blocking reverses HLMVEC-mediated attenuation of MSC's VEGF-A secretion. Together these results suggest that secretion of VEGF-A and immunosuppression are separable functions of MSCs which are regulated by distinct mechanisms in the host. Graphical Abstract
引用
收藏
页码:736 / 751
页数:16
相关论文
共 50 条
  • [31] Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia
    Mcclain-Caldwell, Ian
    Vitale-Cross, Lynn
    Mayer, Balazs
    Krepuska, Miklos
    Boyajian, Michael
    Myneni, Vamsee
    Martin, Daniel
    Nemeth, Krisztian
    Mezey, Eva
    CYTOTHERAPY, 2018, 20 (12) : 1437 - 1444
  • [32] Photoactivation of bone marrow mesenchymal stromal cells with diode laser: Effects and mechanisms of action
    Giannelli, Marco
    Chellini, Flaminia
    Sassoli, Chiara
    Francini, Fabio
    Pini, Alessandro
    Squecco, Roberta
    Nosi, Daniele
    Bani, Daniele
    Zecchi-Orlandini, Sandra
    Formigli, Lucia
    JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (01) : 172 - 181
  • [33] Human mesenchymal progenitor cells derived from alveolar bone and human bone marrow stromal cells: a comparative study
    Pekovits, Karin
    Kroepfl, Julia Maria
    Stelzer, Ingeborg
    Payer, Michael
    Hutter, Heinz
    Dohr, Gottfried
    HISTOCHEMISTRY AND CELL BIOLOGY, 2013, 140 (06) : 611 - 621
  • [34] Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability?
    Merryweather-Clarke, Alison T.
    Cook, David
    Lara, Barbara Joo
    Hua, Peng
    Repapi, Emmanouela
    Ashley, Neil
    Lim, Shiang Y.
    Watt, Suzanne M.
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [35] Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor-Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy
    Serra, Joana
    Alves, Claudia P. A.
    Brito, Liliana
    Monteiro, Gabriel A.
    Cabral, Joaquim M. S.
    Prazeres, Duarte Miguel F.
    da Silva, Claudia L.
    HUMAN GENE THERAPY, 2019, 30 (03) : 316 - 329
  • [36] Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2
    Kanawa, Masami
    Igarashi, Akira
    Ronald, Veronica Sainik
    Higashi, Yukihito
    Kurihara, Hidemi
    Sugiyama, Masaru
    Saskianti, Tania
    Pan, Haiou
    Kato, Yukio
    CYTOTHERAPY, 2013, 15 (09) : 1062 - 1072
  • [37] Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells
    Datta, Indrani
    Mishra, Swati
    Mohanty, Lipsa
    Pulikkot, Sunitha
    Joshi, Preeti G.
    CYTOTHERAPY, 2011, 13 (08) : 918 - 932
  • [38] Targeting eradication of malignant cells derived from human bone marrow mesenchymal stromal cells
    Yang, Yingbin
    Cai, Shaoxi
    Yang, Li
    Yu, Shuhui
    Jiang, Jiahuan
    Yan, Xiaoqing
    Zhang, Haoxing
    Liu, Lan
    Liu, Qun
    Du, Jun
    Cai, Shaohui
    Sung, K. L. Paul
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (20) : 3329 - 3341
  • [39] Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor
    Mittal, Sharad K.
    Foulsham, William
    Shukla, Sachin
    Elbasiony, Elsayed
    Omoto, Masahiro
    Chauhan, Sunil K.
    STEM CELLS TRANSLATIONAL MEDICINE, 2019, 8 (10) : 1030 - 1040
  • [40] Mesenchymal Stem Cells Differentiate to Endothelial Cells Using Recombinant Vascular Endothelial Growth Factor-A
    Khaki, Mohsen
    Salmanian, Ali Hatef
    Abtahi, Hamid
    Ganji, Ali
    Mosayebi, Ghasem
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 6 (02): : 144 - 150